cabozantinib,ipilimumab,nivolumab
exelixis,bms
['9er', 'nivo', 'ipi/', 'gu ', 'rcc,(-irccs),(-srcc),(-urcc)']
updates of 9er cabo/nivo 1st line rcc presented at today s oral gu session &amp; we await results of #pdigree which may continue to change the rcc tx landscape: ipi/nivo followed by cabo vs nivo vs cabo/nivo based on response #asco22 
GU Oncology Fellow | NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | #ASCO22 Featured Voice | COI: https://t.co/X1Y9QuHs6L